19198-Leukemia-CLL-123

Leukemia

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number:

  • Address

3720 South I-35 East
Denton, TX 76210
P: (940) 382-1022

Search by practice name, trial titles, indicators and specific disease types.